BIOMAT Database Logo BIOMAT Database Logo

[Thrombocytes and the von Willebrand factor in ischemic heart disease]. 1988

V N Orlov, and I A Bespal'ko, and E Iu Vasil'eva

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D014841 von Willebrand Factor A high-molecular-weight plasma protein, produced by endothelial cells and megakaryocytes, that is part of the factor VIII/von Willebrand factor complex. The von Willebrand factor has receptors for collagen, platelets, and ristocetin activity as well as the immunologically distinct antigenic determinants. It functions in adhesion of platelets to collagen and hemostatic plug formation. The prolonged bleeding time in VON WILLEBRAND DISEASES is due to the deficiency of this factor. Factor VIII-Related Antigen,Factor VIIIR-Ag,Factor VIIIR-RCo,Plasma Factor VIII Complex,Ristocetin Cofactor,Ristocetin-Willebrand Factor,von Willebrand Protein,Factor VIII Related Antigen,Factor VIIIR Ag,Factor VIIIR RCo,Ristocetin Willebrand Factor

Related Publications

V N Orlov, and I A Bespal'ko, and E Iu Vasil'eva
[Von Willebrand factor, endothelial lesion, and ischemic heart disease].
April 2008, Medicina intensiva,
V N Orlov, and I A Bespal'ko, and E Iu Vasil'eva
von Willebrand disease and von Willebrand factor.
May 2022, Haemophilia : the official journal of the World Federation of Hemophilia,
V N Orlov, and I A Bespal'ko, and E Iu Vasil'eva
Von Willebrand factor and von Willebrand disease.
December 2001, Reviews in clinical and experimental hematology,
V N Orlov, and I A Bespal'ko, and E Iu Vasil'eva
von Willebrand factor and von Willebrand disease.
October 1987, Blood,
V N Orlov, and I A Bespal'ko, and E Iu Vasil'eva
von Willebrand factor and von Willebrand disease.
January 2016, [Rinsho ketsueki] The Japanese journal of clinical hematology,
V N Orlov, and I A Bespal'ko, and E Iu Vasil'eva
[Von Willebrand factor and Von Willebrand disease].
January 2014, Nederlands tijdschrift voor geneeskunde,
V N Orlov, and I A Bespal'ko, and E Iu Vasil'eva
The Cardioprotective Potential of von Willebrand Disease in Ischemic Heart Disease.
July 2022, Texas Heart Institute journal,
V N Orlov, and I A Bespal'ko, and E Iu Vasil'eva
von Willebrand disease and quantitative variation in von Willebrand factor.
September 1997, The Journal of laboratory and clinical medicine,
V N Orlov, and I A Bespal'ko, and E Iu Vasil'eva
Antibodies to von Willebrand factor in von Willebrand disease.
January 1995, Advances in experimental medicine and biology,
V N Orlov, and I A Bespal'ko, and E Iu Vasil'eva
Von Willebrand factor/factor VIII concentrates in the treatment of von Willebrand disease.
March 2009, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis,
Copied contents to your clipboard!